Investigational Drug Information for ATI-450
✉ Email this page to a colleague
What is the drug development status for ATI-450?
ATI-450 is an investigational drug.
There have been 7 clinical trials for ATI-450.
The most recent clinical trial was a Phase 2 trial, which was initiated on March 16th 2020.
The most common disease conditions in clinical trials are Arthritis, Cryopyrin-Associated Periodic Syndromes, and COVID-19. The leading clinical trial sponsors are Aclaris Therapeutics, Inc., University of Kansas Medical Center, and United States Department of Defense.
Summary for ATI-450
| US Patents | 0 |
| International Patents | 23 |
| US Patent Applications | 7 |
| WIPO Patent Applications | 6 |
| Japanese Patent Applications | 2 |
| Clinical Trial Progress | Phase 2 (2020-03-16) |
| Vendors | 11 |
Recent Clinical Trials for ATI-450
| Title | Sponsor | Phase |
|---|---|---|
| Study of ATI-450 vs Placebo in Patients With Moderate to Severe Psoriatic Arthritis | Aclaris Therapeutics, Inc. | Phase 2 |
| ATI-450 Plus MTX Versus Placebo Plus MTX in Patients With Moderate to Severe Active RA | Aclaris Therapeutics, Inc. | Phase 2 |
| ATI-450 vs Placebo in Patients With Moderate to Severe Hidradenitis Suppurativa (HS) | Aclaris Therapeutics, Inc. | Phase 2 |
Clinical Trial Summary for ATI-450
Top disease conditions for ATI-450
Top clinical trial sponsors for ATI-450
US Patents for ATI-450
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for ATI-450
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| ATI-450 | Canada | CA2917344 | 2033-06-07 | ⤷ Try a Trial |
| ATI-450 | China | CN105263326 | 2033-06-07 | ⤷ Try a Trial |
| ATI-450 | China | CN108478579 | 2033-06-07 | ⤷ Try a Trial |
| ATI-450 | Denmark | DK3003039 | 2033-06-07 | ⤷ Try a Trial |
| ATI-450 | European Patent Office | EP3003039 | 2033-06-07 | ⤷ Try a Trial |
| ATI-450 | European Patent Office | EP3845529 | 2033-06-07 | ⤷ Try a Trial |
| ATI-450 | Spain | ES2869048 | 2033-06-07 | ⤷ Try a Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
